IRCT20170207032444N3招募中3 期
The efficacy and safety of Thalidomide in severe Covid19 pneumonia: Arandomized controlled clinical trial
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 75 years（—）
- 性别
- All
入选标准
- •18-75 year old men and 50-75 year old women admitted in hospital
- •Spo2 less than 85% in admission
- •Clinical symptoms and signs compatible with COVID19 infection and positive PCR test or lung HRCT abnormalities compatible with COVID19 pneumonia
- •No need to intubation in first 24 hour of admission
- •No multiorgan failure at presentation
- •No shock state at presentation
- •Obtained informed consent
排除标准
- •Hepatic failure (Child Pugh score = C, AST> 5 times of the upper limit normal)
- •Severe renal dysfunction (GFR less than 30cc per min)
研究者
相似试验
进行中（未招募）
1 期
Efficacy of thalidomide in the treatment of heavy and frequent nose bleeding in patients affected by hereditary hemorrhagic telangiectasiaSevere recurrent epistaxis in hereditary hemorrhagic telangiectasiaMedDRA version: 14.1Level: LLTClassification code 10038554Term: Rendu-Osler-Weber syndromeSystem Organ Class: 10010331 - Congenital, familial and genetic disordersEUCTR2011-004096-36-ITOSPEDALE POLICLINICO S. MATTEO31
进行中（未招募）
1 期
The use of Thalidomide as a treatment for the cachexia of incurable upper gastrointestinal adenocarcinomas:a randomised, double-blinded, placebo controlled trial. - Thalidomide in cancer cachexiaEUCTR2005-000371-18-GBPortsmouth Hospitals Trust180
已完成
3 期
Effect of Thalidomide in Covid 19 pneumoniaPneumonia caused by Coronavirus 2019, COVID19.Coronavirus infection, unspecifiedB34.2IRCT20200428047232N1Esfahan University of Medical Sciences60
招募中
2 期
se of thalidomide in complicated tubercular infection of braiCTRI/2023/05/052417PGIMER Chandigarh
尚未招募
不适用
Addition of oral thalidomide to standard antitubercular regimen for initial 2 months improves the outcome in patients of tubercular meningitis as compared to standard therapy alone.CTRI/2020/08/027438AIIMS Bhubaneswar